ethylmaleimide has been researched along with dynorphins in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, S; Satoh, M; Yokosawa, H | 2 |
| Borsodi, A; Lajtha, A; Zawilska, J | 2 |
| Bakalkin, G; Marinova, Z; Nakagawasai, O; Niijima, F; Sakurada, S; Sato, T; Satoh, S; Tadano, T; Takahashi, H; Tan-No, K; Terenius, L; Yakovleva, T | 1 |
| Arai, Y; Furuta, S; Kotlinska, J; Nakagawasai, O; Niijima, F; Sato, T; Satoh, S; Shimoda, M; Silberring, J; Sugawara, M; Tadano, T; Tan-No, K; Terenius, L; Watanabe, H | 1 |
| Bakalkin, G; Nakagawasai, O; Niijima, F; Sakurada, S; Tadano, T; Takahashi, H; Tan-No, K; Terenius, L | 1 |
| Furuta, S; Kawamura, S; Nakagawasai, O; Niijima, F; Sato, T; Satoh, S; Shimoda, M; Silberring, J; Tadano, T; Tan-No, K; Terenius, L | 1 |
1 review(s) available for ethylmaleimide and dynorphins
| Article | Year |
|---|---|
Nociceptive behavior induced by the endogenous opioid peptides dynorphins in uninjured mice: evidence with intrathecal N-ethylmaleimide inhibiting dynorphin degradation.
Topics: Animals; Cysteine Endopeptidases; Dynorphins; Ethylmaleimide; Injections, Spinal; Ion Channels; Mice; Models, Biological; Pain; Receptors, N-Methyl-D-Aspartate | 2009 |
7 other study(ies) available for ethylmaleimide and dynorphins
| Article | Year |
|---|---|
Characterization of cysteine proteases functioning in degradation of dynorphin in neuroblastoma cells: evidence for the presence of a novel enzyme with strict specificity toward paired basic residues.
Topics: Animals; Cell Line; Chloromercuribenzoates; Chromatography, Gel; Chromatography, High Pressure Liquid; Cysteine Endopeptidases; Dynorphins; Ethylmaleimide; Mice; Molecular Weight; Neuroblastoma; p-Chloromercuribenzoic Acid; Protease Inhibitors | 1989 |
Effect of N-ethylmaleimide treatment on naloxone binding in frog brain membranes.
Topics: Animals; Binding Sites; Brain; Dynorphins; Ethylmaleimide; In Vitro Techniques; Kinetics; Membranes; Morphine; Naloxone; Peptide Fragments; Rana esculenta; Receptors, Opioid; Receptors, Opioid, kappa; Sodium | 1989 |
Degradation of dynorphin-(1-13) and dynorphin-(1-17) by the neuroblastoma cell membrane. Evidence for the involvement of a cysteine protease.
Topics: Amino Acids; Captopril; Cell Line; Cysteine Endopeptidases; Dynorphins; Endopeptidases; Enkephalin, Leucine; Ethylmaleimide; Neuroblastoma; Peptide Fragments | 1986 |
Selective protection of benzomorphan binding sites against inactivation by N-ethylmaleimide. Evidence for kappa-opioid receptors in frog brain.
Topics: Animals; Benzomorphans; Binding Sites; Brain; Cyclazocine; Dynorphins; Ethylketocyclazocine; Ethylmaleimide; Morphinans; Peptide Fragments; Rana esculenta; Receptors, Opioid; Sodium Chloride | 1988 |
Pronociceptive role of dynorphins in uninjured animals: N-ethylmaleimide-induced nociceptive behavior mediated through inhibition of dynorphin degradation.
Topics: Agmatine; Analysis of Variance; Animals; Behavior, Animal; Biguanides; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Dynorphins; Enkephalins; Enzyme Inhibitors; Ethylmaleimide; Excitatory Amino Acid Antagonists; Immune Sera; Injections, Spinal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morphine; Narcotics; Nociceptin Receptor; Piperidines; Protein Precursors; Receptors, Opioid; Spinal Cord; Time Factors | 2005 |
Cysteine protease inhibitors suppress the development of tolerance to morphine antinociception.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Cysteine Proteinase Inhibitors; Drug Tolerance; Dynorphins; Ethylmaleimide; Formaldehyde; Injections, Spinal; Injections, Subcutaneous; Male; Mice; Morphine; Pain Measurement | 2008 |
Suppressive effects by cysteine protease inhibitors on naloxone-precipitated withdrawal jumping in morphine-dependent mice.
Topics: Animals; Cysteine Proteinase Inhibitors; Dipeptides; Dynorphins; Ethylmaleimide; Injections, Intraventricular; Male; Mice; Morphine Dependence; Naloxone; Substance Withdrawal Syndrome | 2010 |